Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Adrenocortical Carcinoma

• Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
• Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas
• Cabozantinib in Combination With Atezolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical Cancer
• Phase 1 Study of 68Ga-R8760
• A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma
• Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.
• First-in-human Evaluation of [18F]CETO
• Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical Carcinoma
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
• Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production
• Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma
• A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
• Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma
• Cabozantinib in Advanced Adrenocortical Carcinoma
• Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
• Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical Carcinoma
• Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
• Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines
• Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma
• Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
• Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
• Nivolumab in Treating Patients With Metastatic Adrenocortical Cancer
• Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma
• A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549
• Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome
• Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma
• Surgery and Heated Chemotherapy for Adrenocortical Carcinoma
• Possible New Therapy for Advanced Cancer
• Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma
• A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients
• Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical Cancer
• Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
• A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
• Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
• Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer Patients
• IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by Surgery
• Efficacy of Adjuvant Mitotane Treatment (ADIUVO)
• Treatment Study Using Bevacizumab for Patients With Adrenocortical Carcinoma
• Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
• Sunitinib in Refractory Adrenocortical Carcinoma
• Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
• Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma
• Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
• Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
• Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
• Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
• Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer
• Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
• Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
• S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
• Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
• A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection